Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Hematologic Cancer
HEMATOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records. -
Caloric Reduction Improves Outcomes for Young People With Acute Lymphoblastic Leukemia
A 10% reduction in calorie intake during the first month of treatment shows promise for augmenting chemotherapy treatment in children and adolescents with ALL. -
Deeper Dives Into the Bone Marrow Microenvironment of Myeloma Cells Provide New Insights Into Novel Therapies and Disease Biology
The immune cells in the microenvironment can reign in myeloma cells but become suppressed and dysregulated during disease progression. -
Recommendations From FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical Trials
A workshop was convened by the US Food and Drug Administration and the American Association for Cancer Research to create recommendations for trial design and later stages of drug development in multiple myeloma.
HEMATOLOGIC CANCER NEWS
Reducing Maintenance Produced ‘Outstanding’ Survival Outcomes in Pediatric Acute Lymphoblastic Leukemia
Gemtuzumab Ozogamicin Can Improve Outcomes in Pediatric KMT2A-Rearranged Acute Myeloid Leukemia
Mobile Wearable Devices Show Some Sleep Disturbances During Multiple Myeloma Treatment
Iberdomide-Based Regimens Show Promise in Relapsed/Refractory Multiple Myeloma
Relapsed, Refractory Follicular Lymphoma: CAR T-Cell Therapy Shows Promise
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
Loading... 
Loading...